Atlas Trials

Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care

Clinical trial NCT03456349 · COMPLETED

Trial details

NCT number
NCT03456349
Sponsor
Nxera Pharma UK Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2017-11-10
Primary completion
2018-07-16
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.